BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 12960556)

  • 1. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
    Yoon MH; Choi JI
    Anesthesiology; 2003 Sep; 99(3):701-7. PubMed ID: 12960556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic of interactions between intrathecal gabapentin and either clonidine or neostigmine in the formalin test.
    Yoon MH; Choi JI; Kwak SH
    Anesth Analg; 2004 May; 98(5):1374-9, table of contents. PubMed ID: 15105218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects between intrathecal clonidine and neostigmine in the formalin test.
    Yoon MH; Yoo KY; Jeong CY
    J Korean Med Sci; 2001 Aug; 16(4):498-504. PubMed ID: 11511797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical cannabinoid antinociception: synergy with spinal sites.
    Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
    Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation for the interaction between intrathecal melatonin and clonidine or neostigmine on formalin-induced nociception.
    Yoon MH; Park HC; Kim WM; Lee HG; Kim YO; Huang LJ
    Life Sci; 2008 Dec; 83(25-26):845-50. PubMed ID: 19000700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test.
    Kang S; Kim CH; Lee H; Kim DY; Han JI; Chung RK; Lee GY
    Anesth Analg; 2007 Mar; 104(3):719-25. PubMed ID: 17312233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.
    Johanek LM; Heitmiller DR; Turner M; Nader N; Hodges J; Simone DA
    Pain; 2001 Sep; 93(3):303-315. PubMed ID: 11514089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
    Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
    Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems.
    Naguib M; Yaksh TL
    Anesthesiology; 1994 Jun; 80(6):1338-48. PubMed ID: 8010479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antinociception of intrathecal sildenafil with clonidine in the rat formalin test.
    Yoon MH; Kim CM; Lee HG; Kim WM; An TH; Kim YO; Huang LJ
    Pharmacol Biochem Behav; 2009 Jun; 92(4):583-8. PubMed ID: 19254741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal adenosine: interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative hypersensitivity.
    Chiari AI; Eisenach JC
    Anesthesiology; 1999 May; 90(5):1413-21. PubMed ID: 10319790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E; Pascual D; Martín MI; Goicoechea C
    Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions.
    Khodayar MJ; Shafaghi B; Naderi N; Zarrindast MR
    J Psychopharmacol; 2006 Jan; 20(1):67-74. PubMed ID: 16174681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
    Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive interaction between spinal clonidine and lidocaine in the rat formalin test: an isobolographic analysis.
    Hao S; Takahata O; Iwasaki H
    Anesth Analg; 2001 Mar; 92(3):733-8. PubMed ID: 11226110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
    Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
    Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM; Simone DA
    Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones.
    Li ZW; Zhang J; Ouyang CH; Li CY; Zhao FB; Liu YW; Ai YX; Hu WP
    Br J Pharmacol; 2009 Dec; 158(8):1904-10. PubMed ID: 19917064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between intrathecal neostigmine and epidural clonidine in human volunteers.
    Hood DD; Mallak KA; Eisenach JC; Tong C
    Anesthesiology; 1996 Aug; 85(2):315-25. PubMed ID: 8712447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.